United States Biotechnology & Medical Research

Inhibikase Therapeutics Inc (IKT)

Track

Track

Inhibikase Therapeutics Inc recorded significant insider trading activity on November 21, 2025, when Sands Capital Life Sciences Pulse Fund II, L.P. acquired over two million shares. This purchase represents the most recent transaction. Previous notable buying occurred in October 2024, involving multiple individuals acquiring substantial equity positions within the firm.
Ticker: IKT Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Inhibikase Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.1
Munshi Amit Non-Executive Director
Transaction date
Purchase
Price
105.47
Quantity 61,467 +16.3%
Value US$1,012,313
Kush Arvind Non-Executive Director
Transaction date
Purchase
Price
251.65
Quantity 63,557 -14.6%
Value US$2,486,352
Bellini Roberto Non-Executive Director
Transaction date
Purchase
Price
1.37
Quantity 1,460,000 +inf%
Value US$2,000,200
1.8
Werner Milton H. President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
0.80
Quantity 5,000 +0.1%
Value US$4,000
1.8
Werner Milton H. President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
0.98
Quantity 5,000 +0.1%
Value US$4,880
1.8
Werner Milton H. President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
0.60
Quantity 10,000 +0.2%
Value US$6,000
3.3
FRATTAROLI JOSEPH Chief Financial Officer Officer
Transaction date
Purchase
Price
0.64
Quantity 3,948 +8.9%
Value US$2,543
1.8
Werner Milton H. President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
1.93
Quantity 400 +1.7%
Value US$772
1.8
Werner Milton H. President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
1.94
Quantity 1,334 +6.0%
Value US$2,588
1.8
Werner Milton H. President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
1.96
Quantity 3,186 +15.6%
Value US$6,245
1.8
Werner Milton H. President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
1.97
Quantity 1,100 +4.9%
Value US$2,167
1.8
Werner Milton H. President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
1.98
Quantity 17,569 +291.8%
Value US$34,787
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-24 2025-11-21 B Purchase
3.1
Sands Capital Life Sciences Pulse Fund II, L.P.
Large shareholder
28,138 -40.4%
24.74
US$1,190,494 		28,138 -40.4% 24.74 US$1,190,494
2024-10-23 2024-10-21 B Purchase
3.1
Munshi Amit
Non-Executive Director
61,467 +16.3%
105.47
US$1,012,313 		61,467 +16.3% 105.47 US$1,012,313
2024-10-23 2024-10-21 B Purchase
Kush Arvind
Non-Executive Director
63,557 -14.6%
251.65
US$2,486,352 		63,557 -14.6% 251.65 US$2,486,352
2024-10-23 2024-10-21 B Purchase
Bellini Roberto
Non-Executive Director
1,460,000 +inf%
1.37
US$2,000,200 		1,460,000 +inf% 1.37 US$2,000,200
2022-08-16 2022-08-16 B Purchase
1.8
Werner Milton H.

President and CEO

Executive Director Large shareholder
5,000 +0.1%
0.80
US$4,000 		5,000 +0.1% 0.80 US$4,000
2022-05-31 2022-05-27 B Purchase
1.8
Werner Milton H.

President and CEO

Executive Director Large shareholder
5,000 +0.1%
0.98
US$4,880 		5,000 +0.1% 0.98 US$4,880
2022-05-23 2022-05-20 B Purchase
1.8
Werner Milton H.

President and CEO

Executive Director Large shareholder
10,000 +0.2%
0.60
US$6,000 		10,000 +0.2% 0.60 US$6,000
2022-05-23 2022-05-19 B Purchase
3.3
FRATTAROLI JOSEPH

Chief Financial Officer

Officer
3,948 +8.9%
0.64
US$2,543 		3,948 +8.9% 0.64 US$2,543
2021-11-19 2021-11-17 B Purchase
1.8
Werner Milton H.

President and CEO

Executive Director Large shareholder
400 +1.7%
1.93
US$772 		400 +1.7% 1.93 US$772
2021-11-19 2021-11-17 B Purchase
1.8
Werner Milton H.

President and CEO

Executive Director Large shareholder
1,334 +6.0%
1.94
US$2,588 		1,334 +6.0% 1.94 US$2,588
2021-11-19 2021-11-17 B Purchase
1.8
Werner Milton H.

President and CEO

Executive Director Large shareholder
3,186 +15.6%
1.96
US$6,245 		3,186 +15.6% 1.96 US$6,245
2021-11-19 2021-11-17 B Purchase
1.8
Werner Milton H.

President and CEO

Executive Director Large shareholder
1,100 +4.9%
1.97
US$2,167 		1,100 +4.9% 1.97 US$2,167
2021-11-19 2021-11-17 B Purchase
1.8
Werner Milton H.

President and CEO

Executive Director Large shareholder
17,569 +291.8%
1.98
US$34,787 		17,569 +291.8% 1.98 US$34,787
Explore more

More insider trading research around Inhibikase Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America